Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Summary

This phase II trial is studying how well temsirolimus works in treating patients with recurrent or persistent cancer of the uterus. Temsirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Timeline

Start

2010-01

Primary completion

2012-04

Completion

2012-10

Drugs

Indications